Loading resource…

ANGWECH ANNET
The presentation discusses the diagnostic criteria for DKA and HHS, emphasizing the importance of recognizing euglycemic DKA, particularly in patients using SGLT inhibitors. It also covers the management of DKA in special populations, such as pregnant women, and outlines the treatment goals for HHS. The document highlights the need for careful monitoring and management of complications associated with these conditions.
No account needed